Phillip Fitzsimmons
@Hennion & Walsh Asset Management, Inc.
Latest period2024 - Q4ReportedManaged Assets$2.209BTotal holdings851
Assets growth rate3.15%Assets growth rate (2-Q avg)6.59%Continuous growth in asset value5 quarters
Portfolio positions
This chart displays the top 10 holdings in Hennion & Walsh Asset Management, Inc.'s 2024 - Q4 portfolio, based on their 13F SEC filing, out of a total of 851 positions.
Assets under management
The assets under management (AUM) of Hennion & Walsh Asset Management, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2024 - Q4, they manage 2.209B in assets, with a quarterly growth rate of 3.15% and a 2-quarter average growth rate of 6.59%. The portfolio is managed by Phillip Fitzsimmons, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BSXBoston Scientific Corp
| 0.44% | $9.588M 107,340 shares@ $89.33 avg price | Increased 7.64% |
EIMEaton Vance Mun Bd Fd
| 0.43% | $9.479M 914,996 shares@ $10.37 avg price | Increased 33.56% |
VRNAVerona Pharma Plc
| 0.41% | $8.996M 193,707 shares@ $46.44 avg price | Increased 24.31% |
MAMastercard Incorporated
| 0.4% | $8.795M 16,702 shares@ $526.57 avg price | Increased 17.21% |
METAMeta Platforms Inc
| 0.4% | $8.768M 14,975 shares@ $585.51 avg price | Increased 7.89% |
BCSFBain Cap Specialty Fin Inc
| 0.38% | $8.205M 468,313 shares@ $17.53 avg price | Increased 0.53% |
TEVATeva Pharmaceutical Inds Ltd
| 0.38% | $8.19M 371,583 shares@ $22.04 avg price | Increased 19.83% |
NOWServicenow Inc
| 0.36% | $7.87M 7,424 shares@ $1060.13 avg price | Increased 11.9% |
SRLNSsga Active Etf Tr
| 0.36% | $7.825M 187,509 shares@ $41.74 avg price | Increased 33.09% |
MRKMerck & Co Inc
| 0.34% | $7.441M 74,801 shares@ $99.49 avg price | Increased 7.31% |